MICHELLE HOLLOWAY: Open Payments
NPI 1235166364 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,894 in 30 payments from 6 companies in 2025. Trend: 2023 $979 · 2024 $40,870 · 2025 $4,894
Speaker / faculty: $4,125Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| Noven Therapeutics, LLC | 12 | $4,375 |
| Otsuka America Pharmaceutical, Inc. | 9 | $317 |
| ABBVIE INC. | 5 | $118 |
| Bausch Health US, LLC | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Tris Pharma Inc | 1 | $17 |
Products named: Xelstrym, REXULTI, VRAYLAR, APLENZIN, Jornay PM, Dyanavel XR.
Industry payments across OK — which companies pay providers there.
